THE METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE®) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENT
Authors:
- 1 July 1967
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 43 (3) , 348-356
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Relative Anticonvulsant Potency of PrimidoneArchives of Neurology, 1966
- N‐mythelated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsyNeurology, 1958
- Metabolic Conversion of Primidone (Mysoline) to Phenobarbital.Experimental Biology and Medicine, 1956
- Erfahrungen mit Mylepsin1in der EpilepsiebehandlungDMW - Deutsche Medizinische Wochenschrift, 1956
- Primidone (Mysoline) in the Treatment of EpilepsyNew England Journal of Medicine, 1956
- A Note on A Urinary Metabolite of PhenobarbitoneJournal of Pharmacy and Pharmacology, 1955
- Effects of Liver Damage and Nephrectomy on Anticonvulsant Activity of Mysoline and Phenobarbital*Journal of the American Pharmaceutical Association (Scientific ed.), 1954
- PRIMIDONE IN THE TREATMENT OF NON-IDIOPATHIC EPILEPSYThe Lancet, 1954
- THE EVALUATION OF “MYSOLINE”—A NEW ANTICONVULSANT DRUGBritish Journal of Pharmacology and Chemotherapy, 1953
- MYSOLINE IN THE TREATMENT OF EPILEPSYThe Lancet, 1953